Differences in utilization rates between commercial and administrative databases: Implications for future health-economic and cross-national studies

Kristina Garuoliene, Brian Godman*, Jolanta Gulbinovič, Krijn Schiffers, Björn Wettermark

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

16 Citations (Scopus)
Original languageEnglish
Pages (from-to)149-152
Number of pages4
JournalExpert Review of Pharmacoeconomics and Outcomes Research
Issue number2
Publication statusPublished - 3 Mar 2016
Externally publishedYes


  • Lithuania
  • PPIs
  • administrative databases
  • antidepressants
  • budget impact analysis
  • commercial databases
  • drug utilization studies
  • health economics
  • health policy
  • renin-angiotensin inhibitors
  • statins

Cite this